Mr. Withrow is a successful natural products and technology entrepreneur with over 25 years experience in public markets. He has an extensive business network throughout the Americas and Pacific Rim, and his experience in international trade and regulatory compliance have been essential to the companies that he has structured and led.
With a background of starting many agricultural-type companies and helping them to grow, he has worked with and led companies such as CAVA Health Care (formerly Alternative Extracts Inc.), North American BioExtracts Inc., and Canadian Pacific Phytoplankton Ltd. Mr. Withrow has expanded his company, CanViet Enterprises Inc., internationally and met the opportunities where they resided. He was instrumental in securing millions of dollars in public and private investments to fund the working capital requirements of his high-growth companies. In addition, Mr. Withrow has also held senior advisory positions for a number of companies.
Mr. Withrow is the founder of the company and has been the Chairman of the Board of AREV since inception. He has also served as the President, CEO of Abattis Bioceuticals Corp. from 2011 – 2015. Abattis Bioceuticals Corp. a specialty cannabis company producing, licensing and marketing proprietary ingredients and products containing standardized phytochemicals for sale in the pharmaceuticals, nutraceuticals, cosmetics, and animal nutrition markets.
He also served in directorships/management positions with North American BioExtracts Inc. (2010-2015), with Canadian Pacific Phytoplankton Ltd. and Canadian Pacific Algae Inc. (2008-2010) and with BFuel Canada (2006-2007).
Mr. Kevin Phelps is a successful biotech and general business professional with over 30 years’ experience in business assessment, business development, commercialization, operations, mergers/acquisitions, capital formation, franchising and licensing. Kevin has been a member of numerous executive teams as CEO, CFO and VP Business Development. He has successfully managed and sold several entrepreneurial businesses and raised millions of dollars in early and growth stage capital.
Currently, Mr. Phelps is Chief Executive Officer and President of Immune Therapeutics, Inc., an OTC listed (IMUN) bio-pharmaceutical company. He was originally recruited to Immune in November 2018 as a Director. In April 2020 he was voted in as President and CEO.
Kevin began his career as a CPA with Price Waterhouse Coopers specializing in services to emerging growth companies. In 1987 he was recruited to the Eastman Kodak Company and as part of an executive team successfully executed the spinout of the Bio Products Division into Genencor International, Inc., an international industrial bio-chemicals company. Mr. Phelps served as Chief Financial Officer and VP of Business Development. In those capacities he was directly responsible for executing the formation strategy of the new Company and later the acquisition of two European chemical company competitors.
Following Genencor, Mr. Phelps joined Trillium Group, a regional private equity firm, as a partner, during which time he underwrote and developed a portfolio of small growth companies including several in the drug development and medical device sectors. While there he served on behalf of the firm as CFO of Vaccinex, Inc., a vaccine development company and Chairman of AccuMed, Inc., a medical device company.
Mr. Phelps graduated from the University of Notre Dame with a degree in Accounting. He is a former CPA and has been active in Upstate New York venture capital community. In addition to the AREV Board, he currently serves on the Boards of OyaGen, Inc. (Chairman), Immune Therapeutics, Inc., and Rochester Friendly Senior Services (Treasurer).
Ms. Greenslade has worked as a Corporate Secretary and Director for several companies in the mining, biotech and IT industries and is constantly updating her business training.
She is responsible for the creation and regulation of the Company’s corporate governance structures, policies and mechanisms; corporate communication, conduct and regulatory compliance in both Canada and the United States; Board and shareholder meetings and communication; office and personnel management; creation and administration of company policies and procedures; and implementation of corporate-wide management and document retention systems.
Ms. Greenslade has over 15 years of corporate secretarial, corporate governance, and securities regulation experience with a focus on the nutraceutical and mining sector in Canada and Mexico. She has served in several senior management and executive roles for companies listed on the Toronto Stock Exchange, TSX Venture Exchange and Canadian Stock Exchange.
During her career, she has been involved in numerous transactions and financings, and has led the evaluation, design, implementation and monitoring of governance programs for several junior mining companies.
Ms. Greenslade graduated from Simon Fraser University, British Columbia with a Bachelor of Arts in Communication and further attended BCIT to complete an associate certificate in Graphic Design.
Mr. Cameron has owned and operated a corporate finance consultancy, Cameron & Associates, since 1983, with offices in Vancouver Canada, Seattle Washington and Phoenix, Arizona. Prior to forming Cameron & Associates, Mr. Cameron was employed by Price Waterhouse Chartered Accountants and subsequently served in various securities regulatory capacities with the British Columbia Securities Commission and the Vancouver Stock Exchange. Cameron & Associates has provided capital formation strategic planning, business plan preparation, integration of private and public capital formation processes, educational support on capital formation processes for clients, formal business valuation services, technical report preparation, regulatory consulting and regulatory conflict resolution for over 30 years. Mr. Cameron has served as CFO and/ or Acting CFO for public companies in both Canada and the United States as well as Corporate Secretary for certain client engagements. Regulation and compliance are the drivers for Cameron & Associate and the engagements undertaken.